Potential of aspirin to inhibit thrombotic microangiopathy in α1,3-galactosyltransferase gene-knockout pig hearts after transplantation in baboons

F. J.M.F. Dor, K. Kuwaki, Y. L. Tseng, A. Shimizu, S. L. Houser, K. Yamada, R. J. Hawley, C. Patience, M. Awwad, J. A. Fishman, S. C. Robson, D. H. Sachs, H. J. Schuurman, D. K.C. Cooper

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

Hearts from α1,3-Galactosyltransferase gene-knockout (GaIT-KO) pigs were transplanted heterotopically into 8 baboons that received an anti-CD154 monoclonal antibody (mAb)-based immunosuppressive regimen and heparin. Three baboons died or were euthanized with beating grafts on 16, 23, and 56 days, respectively, and the remaining 5 grafts functioned for 59-179 days. Hyperacute rejection did not occur, and classical features of acute humoral xenograft or acute cellular rejection were rare. However, thrombotic microangiopathy (TM) developed in all cases; its onset was delayed in 2 baboons that received aspirin. Function of a pig organ in a baboon for a period approaching 6 months has not been reported previously and lends encouragement that the barriers to xenotransplantation will be overcome, but TM requires investigation.

Original languageEnglish
Pages (from-to)489-490
Number of pages2
JournalTransplantation Proceedings
Volume37
Issue number1
DOIs
Publication statusPublished - 2005

All Science Journal Classification (ASJC) codes

  • Surgery
  • Transplantation

Fingerprint

Dive into the research topics of 'Potential of aspirin to inhibit thrombotic microangiopathy in α1,3-galactosyltransferase gene-knockout pig hearts after transplantation in baboons'. Together they form a unique fingerprint.

Cite this